Close Menu

NEW YORK – Newly public diagnostic firm Progenity announced Thursday it has settled with the US Department of Justice and the US Department of Health and Human Services to resolve allegations of improper business, promotional, and billing practices.

Under the agreement, the company will pay $35.8 million to settle the federal complaints and won't be prosecuted by the DOJ. Progenity also expects to pay an additional $13.2 million to various state attorneys general to resolve additional claims.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.